Skip to news
JQJO
Latest

FDA Recommends Ban on Potent Kratom Derivative | JQJO

FDA Recommends Ban on Potent Kratom Derivative

FDA Recommends Ban on Potent Kratom Derivative

Tap title to read story

0:00 / 0:42

U.S. health officials are recommending a nationwide ban on 7-hydroxymitragynine (7-OH), a kratom derivative found in energy drinks and supplements. The FDA considers 7-OH a potent opioid, more powerful than morphine, posing a risk of addiction and overdose. This follows recent FDA warnings to companies selling 7-OH-infused products. While some in the kratom industry support the ban, others oppose further regulation of kratom. The DEA will review the FDA's recommendation to place 7-OH on the most restrictive list of illegal drugs, a process that could lead to a federal ban.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

OpenAI Cuts Funding Target to Twenty

Tap title to read story

0:00 / 0:37

Commanders Face Injury Woes Ahead

Tap title to read story

0:00 / 0:39

JQJO

Find your next story

Search JQJO’s current coverage.